Meta-Analysis
Copyright ©The Author(s) 2021.
World J Meta-Anal. Feb 28, 2021; 9(1): 74-87
Published online Feb 28, 2021. doi: 10.13105/wjma.v9.i1.74
Table 4 Sensitivity analysis of efficacy and safety outcomes based on the risk of bias assessment and study design
Variable
All studies
Sensitivity analysis(risk of bias assessment)
Sensitivity analysis (study design)
RR (95%CI)
I2
RR (95%CI)
I2
RR (95%CI)
I2
Mortality0.83 (0.57-1.20)590.83 (0.55-1.26)730.74 (0.38-1.44)65
Ventilation0.69 (0.41-1.18)770.73 (0.42-1.27)830.57 (0.41-0.77)00
Composite mortality and ventilation0.80 (0.58-1.11)780.83 (0.60-1.16)840.69 (0.55-0.86)10
Clinical recovery1.10 (1.04-1.16)001.10 (1.02-1.18)001.10 (1.02-1.18)00
Adverse event1.05 (0.86-1.27)770.94 (0.86-1.02)000.94 (0.86-1.02)00
Grade 3 or 4 adverse event0.89 (0.80-0.99)000.87 (0.71-1.07)100.87 (0.71-1.07)10
Serious adverse event0.75 (0.63-0.90)000.76 (0.64-0.92)000.76 (0.64-0.92)00